Evidence map›Paper›PMID 38826353›Full record

ArticlemedRxiv : the preprint server for health sciences2024

The textures of sarcoidosis: quantifying lung disease through variograms.

William L Lippitt, Lisa A Maier, Tasha E Fingerlin, David A Lynch, Ruchi Yadav, Jared Rieck, Andrew C Hill, Shu-Yi Liao, Margaret M Mroz, Briana Q Barkes and 3 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

William L LippittDept of Biostatistics and Informatics, Uni. of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0001-8494-3126
Lisa A MaierDept of Medicine, National Jewish Health, Denver, CO, USA.
Tasha E FingerlinDept of Biostatistics and Informatics, Uni. of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0002-6405-3705
David A LynchDept of Radiology, National Jewish Health, Denver, CO, USA.ORCID 0000-0002-6329-2325
Ruchi YadavDept of Diagnostic Radiology, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0002-4892-438X
Jared RieckDept of Biostatistics and Informatics, Uni. of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0009-0006-8705-8361
Andrew C HillDept of Biostatistics and Informatics, Uni. of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Shu-Yi LiaoDept of Medicine, National Jewish Health, Denver, CO, USA.ORCID 0000-0001-9477-3837
Margaret M MrozDept of Medicine, National Jewish Health, Denver, CO, USA.
Briana Q BarkesDept of Medicine, National Jewish Health, Denver, CO, USA.
Kum Ju ChaeDept of Radiology, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Jeollabuk-do, Korea.ORCID 0000-0003-3012-3530
Hye Jeon HwangDept of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 86 Asanbyeongwon-Gil, Songpa-Gu, Seoul, Korea.ORCID 0000-0003-3508-2870
Nichole E CarlsonDept of Biostatistics and Informatics, Uni. of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0003-0679-6663

Funding

MULTIDISCIPLINARY RESPIRATORY DISEASES RESEARCH TRAININGT32HL007085 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ELLEN L BURNHAM, LISA A MAIER · 1985 to 2026
$21.6M
Sarcoidosis and A1AT Genomics & Informatics CenterU01HL112707 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BECICH, MICHAEL JOHN, KAMINSKI, NAFTALI · 2012 to 2015
$8.5M
A Prospective Study of T cell Immune-phenotype and Disease Outcome in Pulmonary SarcoidosisR01HL136681 · NHLBI · NATIONAL JEWISH HEALTH · PI HAMZEH, NABEEL, KOTH, LAURA L · 2018 to 2021
$4.0M
Genetic Risk for Granulomatous Interstitial Lung DiseaseR01HL114587 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FINGERLIN, TASHA E. · 2013 to 2018
$3.2M
Multi-omic networks associated with COPD progression in TOPMed CohortsR01HL152735 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BANAEI-KASHANI, FARNOUSH, BOWLER, RUSSELL PAUL · 2020 to 2023
$3.1M
Epigenetic Regulation of Immune Pathways in SarcoidosisR01HL140357 · NHLBI · NATIONAL JEWISH HEALTH · PI MAIER, LISA A, YANG, IVANA V · 2018 to 2021
$2.8M
Novel integrative approaches for disease phenotyping, utilizing radiomics in SarcoidosisR01HL142049 · NHLBI · NATIONAL JEWISH HEALTH · PI CARLSON, NICHOLE, FINGERLIN, TASHA E. · 2019 to 2022
$2.6M
Significance Circulating Semaphorin 7a+ve Cells in Pulmonary SarcoidosisU01HL112702 · NHLBI · YALE UNIVERSITY · PI HERZOG, ERICA L · 2012 to 2014
$488k
GRADS Cooperative Research Project: JHU Clinical CenterU01HL112708 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI MOLLER, DAVID R · 2012 to 2014
$481k
Genomic Phenotyping and Mechanisms in sarcoidosis and AATU01HL112696 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GARCIA, JOE G. N., KOTH, LAURA L · 2012 to 2014
$470k
GRADS Clinical Center: Studies in Sarcoidosis and Microbiomics ResearchU01HL112712 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI COLLMAN, RONALD G, ROSSMAN, MILTON DAVID · 2012 to 2014
$469k
Immunologic and Molecular Phenotypes in AATD and SarcoidosisU01HL112695 · NHLBI · NATIONAL JEWISH HEALTH · PI MAIER, LISA A · 2012 to 2014
$465k
NHLBI NIH HHS R01 HL114587NHLBI NIH HHS R01 HL136681NHLBI NIH HHS R01 HL140357NHLBI NIH HHS R01 HL142049NHLBI NIH HHS R01 HL152735NHLBI NIH HHS T32 HL007085NHLBI NIH HHS U01 HL112694NHLBI NIH HHS U01 HL112695NHLBI NIH HHS U01 HL112696NHLBI NIH HHS U01 HL112702NHLBI NIH HHS U01 HL112707NHLBI NIH HHS U01 HL112708NHLBI NIH HHS U01 HL112711NHLBI NIH HHS U01 HL112712
6 · The paper itself

Abstract

Objective: Sarcoidosis is a granulomatous disease affecting the lungs in over 90% of patients. Qualitative assessment of chest CT by radiologists is standard clinical practice and reliable quantification of disease from CT would support ongoing efforts to identify sarcoidosis phenotypes. Standard imaging feature engineering techniques such as radiomics suffer from extreme sensitivity to image acquisition and processing, potentially impeding generalizability of research to clinical populations. In this work, we instead investigate approaches to engineering variogram-based features with the intent to identify a robust, generalizable pipeline for image quantification in the study of sarcoidosis. Approach: For a cohort of more than 300 individuals with sarcoidosis, we investigated 24 feature engineering pipelines differing by decisions for image registration to a template lung, empirical and model variogram estimation methods, and feature harmonization for CT scanner model, and subsequently 48 sets of phenotypes produced through unsupervised clustering. We then assessed sensitivity of engineered features, phenotypes produced through unsupervised clustering, and sarcoidosis disease signal strength to pipeline. Main results: We found that variogram features had low to mild association with scanner model and associations were reduced by image registration. For each feature type, features were also typically robust to all pipeline decisions except image registration. Strength of disease signal as measured by association with pulmonary function testing and some radiologist visual assessments was strong (optimistic AUC ≈ 0.9, Significance: Variogram-based features appear to be a suitable approach to image quantification in support of generalizable research in pulmonary sarcoidosis.

Indexed as

computed tomographyquantitative imagingradiomicsrobustnesssarcoidosisvariograms

Identifiers

PMID38826353
PMCPMC11142277

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.